Wenger Vieli advised Hoerbiger, a globally active technology group, on all Swiss legal aspects in connection with the acquisition of PI. Headquartered in Karlsruhe, PI is a provider high-precision motion and positioning solutions for
Schellenberg Wittmer advised Aggreko Holdings on its acquisition of MiT Energie Holding , a Swiss provider of mobile energy solutions and water damage restoration, active in the DACH-region. In connection with the deal, DLA Piper
Lenz & Staehelin advised Veeam Software — a portfolio company of Insight Partners specialised in the development of data backup, data recovery and data protection solutions — in connection with its acquisition of Object First, a provider
Baker McKenzie advised Swiss real estate developer Plazza on its placement of a fixed-rate bond amounting CHF 100 million, with a coupon of 1.25%, a maturity of 5.2 years and due on 31 March 2031. UBS, Zürcher Kantonalbank and
Homburger advised UBS Group on a of EUR 3 notes issuance under the bank’s senior debt programme. The operation includes two tranches of EUR 1.5 bn each, respectively due February 2031 and January 2037. The notes in question
Walder Wyss advised Crédit Mutuel Equity (CME), as the company was appointed — together with IDIA Capital Investissement — by Polenghi, to lead a new investment round, following the exit of Progressio SGR. Headquartered in Italy,
Homburger advised Baseline Wealth Management, a wealth management specialist with headquarters in Zurich and Geneva, in connection with the company’s sale to US-based Creative Planning. The Homburger team Frank Gerhard (corporate/M&A,
Private equity investor Afinium has entered into an agreement to sell Threema — a provider of digital communication solutions for enterprises and public institutions — to Comitis Capital. In connection with the deal, Vischer advised Afinium, while
Kellerhals Carrard advised P&F Immobilien on its internal reorganization and the subsequent sale of all shares in P&F Immobilien II to SFP Retail. The deal’s object, P&F Immobilien
Walder Wyss advised TECregen, as the Basel-based biotechnology company raised CHF 10 million in a seed financing round. The investor base Boehringer Ingelheim Venture Fund (BIVF) led the round in question, with participation from LifeSpan
